Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebban

Showing results (381-390 of 459) with videos related to

Pageof 46
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidolM J Millan, R Schreiber, A Dekeyne, et al.
The Oncologist|October 10, 2013
A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphomaAndré Bosly, Andrew Grigg, Harald Holte, et al.
Cell Stem Cell|September 29, 2015
Extensive Nuclear Reprogramming Underlies Lineage Conversion into Functional Trophoblast Stem-like CellsHana Benchetrit, Shay Herman, Niek van Wietmarschen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.
Genes, Chromosomes & Cancer|August 1, 2020
A versatile system to introduce clusters of genomic double-strand breaks in large cell populationsThorsten Kolb, Umar Khalid, Milena Simović, et al.
Journal of Neurochemistry|June 20, 2012
Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineSophie Schumm, Claude Sebban, Charles Cohen-Salmon, et al.
Nucleic Acids Research|July 10, 2018
Germline DNA replication timing shapes mammalian genome compositionYishai Yehuda, Britny Blumenfeld, Nina Mayorek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study groupFranck Morschhauser, Pauline Brice, Christophe Fermé, et al.
Leukemia|September 26, 1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic LeukemiaA Delannoy, C Sebban, P Cony-Makhoul, et al.
ACS Omega|February 21, 2022
Fluorocyclopropane-Containing Proline Analogue: Synthesis and Conformation of an Item in the Peptide Chemist's ToolboxAmandine Pons, Jonathan Decaens, Riham Najjar, et al.
Pageof 46

Showing results (381-390 of 459) with videos related to

Sort By:
Pageof 46
The Journal of Pharmacology and Experimental Therapeutics|September 11, 1998
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidolM J Millan, R Schreiber, A Dekeyne, et al.
The Oncologist|October 10, 2013
A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphomaAndré Bosly, Andrew Grigg, Harald Holte, et al.
Cell Stem Cell|September 29, 2015
Extensive Nuclear Reprogramming Underlies Lineage Conversion into Functional Trophoblast Stem-like CellsHana Benchetrit, Shay Herman, Niek van Wietmarschen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trialC Guglielmi, F Gomez, T Philip, et al.
Genes, Chromosomes & Cancer|August 1, 2020
A versatile system to introduce clusters of genomic double-strand breaks in large cell populationsThorsten Kolb, Umar Khalid, Milena Simović, et al.
Journal of Neurochemistry|June 20, 2012
Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineSophie Schumm, Claude Sebban, Charles Cohen-Salmon, et al.
Nucleic Acids Research|July 10, 2018
Germline DNA replication timing shapes mammalian genome compositionYishai Yehuda, Britny Blumenfeld, Nina Mayorek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study groupFranck Morschhauser, Pauline Brice, Christophe Fermé, et al.
Leukemia|September 26, 1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic LeukemiaA Delannoy, C Sebban, P Cony-Makhoul, et al.
ACS Omega|February 21, 2022
Fluorocyclopropane-Containing Proline Analogue: Synthesis and Conformation of an Item in the Peptide Chemist's ToolboxAmandine Pons, Jonathan Decaens, Riham Najjar, et al.
Pageof 46